Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination.
Joint Clinical Trials Office
A Phase II Study of Daratumumab, Clarithromycin, Pomalidomide, and Dexamethasone (D-ClaPd) In Multiple Myeloma Patients Previously Exposed to Daratumumab
Study Status:
Open to Enrollment
Primary Investigator:
Date: April 18, 2022
An Open Label, Phase 1, Treatment Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of IDE397 (MAT2A Inhibitor) In Adult Participants with Advanced Solid Tumors
Study Status:
Open to Enrollment
Primary Investigator:
Date: April 25, 2022
A Phase 1b/2 Study of IMGN632 as Monotherapy or Combination with Venetoclax and/or Azacitidine for Patients with CD123-Positive Acute Myeloid Leukemia
Study Status:
Open to Enrollment
Primary Investigator:
Date: May 3, 2022
Phase 1b/2 Open-Label Multicenter, Dose Optimization Clinical Study of Safety, Tolerability, Pharmacokinetic & Pharmacodynamic Profiles of CFI-400945 as a Single Agent or in Combination with Azacitidine or Decitabine in Patients With AML, MDS, or CMML
Study Status:
Open to Enrollment
Primary Investigator:
Date: May 5, 2022
Doxycycline for Emphysema in People Living with HIV
Study Status:
Open to Enrollment
Primary Investigator:
Date: June 9, 2022
A Phase 1, Multicenter, Open-label, Dose-escalation, and Dose-expansion Study to Evaluate the Safety, Pharmacokinetics, and Anti-tumor Activity of ARX517 in Subjects with Advanced Solid Tumors Resistant or Refractory to Standard Therapies
Study Status:
Open to Enrollment
Primary Investigator:
Date: August 9, 2022
A Phase 1/2, Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Chaperone-mediated Protein Degrader RNK05047 in Subjects with Advanced Solid Tumors (CHAMP-1)
Study Status:
Open to Enrollment
Primary Investigator:
Date: August 17, 2022
Intra-Arterial (IA) Chemotherapy for Newly Diagnosed, Residual, or Recurrent Atypical Choroid Plexus Papilloma (ACPP) and Choroid Plexus Carcinoma (CPC) Prior to Second-Look Surgery
Study Status:
Open to Enrollment
Primary Investigator:
Date: August 17, 2022
Engage & Connect: A novel, neuroscience-informed streamlined psychotherapy for postpartum depression
Study Status:
Open to Enrollment
Primary Investigator:
Date: August 18, 2022
A Digital Intervention for Post-Stroke Depression and Executive Dysfunction
Study Status:
Open to Enrollment
Primary Investigator:
Date: September 14, 2022